R
Roberto Bertollini
Researcher at Qatar Airways
Publications - 136
Citations - 8734
Roberto Bertollini is an academic researcher from Qatar Airways. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 27, co-authored 88 publications receiving 4379 citations. Previous affiliations of Roberto Bertollini include Democratic Republic of the Congo Ministry of Health & World Health Organization.
Papers
More filters
Journal ArticleDOI
The Lancet Commission on pollution and health
Philip J. Landrigan,Richard Fuller,Nereus J R Acosta,Olusoji Adeyi,Robert G. Arnold,Niladri Basu,Abdoulaye Bibi Baldé,Roberto Bertollini,Stephan Bose-O'Reilly,Stephan Bose-O'Reilly,Jo Ivey Boufford,Patrick N. Breysse,Thomas C. Chiles,Chulabhorn Mahidol,Awa M Coll-Seck,Maureen L. Cropper,Julius N. Fobil,Valentin Fuster,Valentin Fuster,Michael Greenstone,Andy Haines,David Hanrahan,David J. Hunter,Mukesh Khare,Alan Krupnick,Bruce P. Lanphear,Bindu Lohani,Keith Martin,Karen V Mathiasen,Maureen A. McTeer,Christopher J L Murray,Johanita D Ndahimananjara,Frederica P. Perera,Janez Potočnik,Alexander S Preker,Alexander S Preker,Jairam Ramesh,Johan Rockström,Carlos Salinas,Leona D. Samson,Karti Sandilya,Peter D. Sly,Kirk R. Smith,Achim Steiner,Richard B. Stewart,William A. Suk,Onno C. P. van Schayck,Gautam N. Yadama,Kandeh K. Yumkella,Ma Zhong +49 more
TL;DR: This book is dedicated to the memory of those who have served in the armed forces and their families during the conflicts of the twentieth century.
Posted ContentDOI
Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar
Hiam Chemaitelly,Hiam Chemaitelly,Patrick Tang,Mohammad Rubayet Hasan,Sawsan AlMukdad,Sawsan AlMukdad,Hadi M. Yassine,Hadi M. Yassine,Fatiha M. Benslimane,Fatiha M. Benslimane,Hebah A. Al Khatib,Hebah A. Al Khatib,Peter Coyle,Peter Coyle,Peter Coyle,Houssein H. Ayoub,Zaina Al Kanaani,Einas Al Kuwari,Andrew Jeremijenko,Anvar Hassan Kaleeckal,Ali Nizar Latif,Riyazuddin Mohammad Shaik,Hanan F. Abdul Rahim,Gheyath K. Nasrallah,Gheyath K. Nasrallah,Mohamed Ghaith Al Kuwari,Hamad Eid Al Romaihi,Adeel A. Butt,Adeel A. Butt,Mohamed H. Al-Thani,Abdullatif Al Khal,Roberto Bertollini,Laith J. Abu-Raddad +32 more
TL;DR: In this article, the authors investigated the persistence of BNT162b2 (Pfizer-BioNTech) vaccine effectiveness against infection and disease in Qatar, where the Beta and Delta variants have dominated incidence and PCR testing is done at a mass scale.
Journal ArticleDOI
Knowns and unknowns on burden of disease due to chemicals: a systematic review
TL;DR: The known burden due to chemicals is considerable and supports decision-making in programmes having a role to play in reducing human exposure to toxic chemicals.
Journal ArticleDOI
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar.
Patrick Tang,Mohammad Rubayet Hasan,Hiam Chemaitelly,Hiam Chemaitelly,Hadi M. Yassine,Hadi M. Yassine,Fatiha M. Benslimane,Fatiha M. Benslimane,Hebah A. Al Khatib,Hebah A. Al Khatib,Sawsan AlMukdad,Sawsan AlMukdad,Peter Coyle,Peter Coyle,Peter Coyle,Houssein H. Ayoub,Zaina Al Kanaani,Einas Al Kuwari,Andrew Jeremijenko,Anvar Hassan Kaleeckal,Ali Nizar Latif,Riyazuddin Mohammad Shaik,Hanan F. Abdul Rahim,Gheyath K. Nasrallah,Gheyath K. Nasrallah,Mohamed Ghaith Al Kuwari,Hamad Eid Al Romaihi,Adeel A. Butt,Adeel A. Butt,Mohamed H. Al-Thani,Abdullatif Al Khal,Roberto Bertollini,Laith J. Abu-Raddad +32 more
TL;DR: In this article, the authors conducted a matched test-negative case-control study to assess the real-world effectiveness of COVID-19 messenger RNA vaccines against infection with Delta in Qatar's population.
Journal ArticleDOI
mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar.
Hiam Chemaitelly,Hiam Chemaitelly,Hadi M. Yassine,Hadi M. Yassine,Fatiha M. Benslimane,Fatiha M. Benslimane,Hebah A. Al Khatib,Hebah A. Al Khatib,Patrick Tang,Mohammad Rubayet Hasan,Joel A. Malek,Peter Coyle,Peter Coyle,Peter Coyle,Houssein H. Ayoub,Zaina Al Kanaani,Einas Al Kuwari,Andrew Jeremijenko,Anvar Hassan Kaleeckal,Ali Nizar Latif,Riyazuddin Mohammad Shaik,Hanan F. Abdul Rahim,Gheyath K. Nasrallah,Gheyath K. Nasrallah,Mohamed Ghaith Al Kuwari,Hamad Eid Al Romaihi,Mohamed H. Al-Thani,Abdullatif Al Khal,Adeel A. Butt,Adeel A. Butt,Roberto Bertollini,Laith J. Abu-Raddad,Laith J. Abu-Raddad +32 more
TL;DR: The mRNA-1273 (Moderna) vaccine was reported to have an efficacy of 94.1% at preventing symptomatic COVID-19 due to infection with ‘wild-type’ variants in a randomized clinical trial.